SK288052B6 - Polymorph 1 of bilastine, process for preparing thereof, its antihistaminic and antiallergic use and pharmaceutical preparation containing it - Google Patents
Polymorph 1 of bilastine, process for preparing thereof, its antihistaminic and antiallergic use and pharmaceutical preparation containing it Download PDFInfo
- Publication number
- SK288052B6 SK288052B6 SK5020-2004A SK50202004A SK288052B6 SK 288052 B6 SK288052 B6 SK 288052B6 SK 50202004 A SK50202004 A SK 50202004A SK 288052 B6 SK288052 B6 SK 288052B6
- Authority
- SK
- Slovakia
- Prior art keywords
- bilastine
- polymorph
- antihistaminic
- preparing
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (2)
- PATENTOVÉ NÁROKY1. Polymorf 1 bilastínu, vyznačujúci sa tým, že jeho rôntgenová kryštalografická analýza má nasledujúce kryštalické parametre:kryštalografická sústava jednoklonná priestorová grupa P2 (1 )/c veľkosť kryštálu 0,56 x 0,45 x 0,24 mm veľkosť bunky a = 2, 338 (5) nm a = 90° b = 0,8829 (17) ηιηβ = 90ο c =1,259 (2) nm γ =90° objem 2,6 nm3Z, vypočítaná hustota 4, 1,184 mg/m3.
- 2. Polymorf 1 bilastínu podľa nároku 1, vyznačujúci sa tým, že má infračervené spektrum v bromide draselnom s nasledujúcimi pásmi:vlnočet (cm'1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/ES2002/000194 WO2003089425A1 (es) | 2002-04-19 | 2002-04-19 | POLIMORFO DEL ÁCIDO 4-[2-[4-[1-(2-ETOXIETIL)-1H-BENCIMIDAZOL-2-IL]-1-PIPERIDINIL]ETIL]-α, α-DIMETIL-BENCENOACÉTICO |
Publications (2)
Publication Number | Publication Date |
---|---|
SK50202004A3 SK50202004A3 (sk) | 2005-05-05 |
SK288052B6 true SK288052B6 (sk) | 2013-03-01 |
Family
ID=29225789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK5020-2004A SK288052B6 (sk) | 2002-04-19 | 2002-04-19 | Polymorph 1 of bilastine, process for preparing thereof, its antihistaminic and antiallergic use and pharmaceutical preparation containing it |
Country Status (31)
Country | Link |
---|---|
US (2) | US7612095B2 (sk) |
EP (1) | EP1505066B1 (sk) |
JP (1) | JP5142448B2 (sk) |
KR (1) | KR100673140B1 (sk) |
CN (1) | CN1290843C (sk) |
AR (1) | AR039423A1 (sk) |
AT (1) | ATE347550T1 (sk) |
AU (1) | AU2002255017B2 (sk) |
BG (1) | BG66302B1 (sk) |
BR (1) | BRPI0215703B8 (sk) |
CA (1) | CA2484460C (sk) |
CY (2) | CY1107564T1 (sk) |
CZ (1) | CZ305162B6 (sk) |
DE (1) | DE60216641T2 (sk) |
DK (1) | DK1505066T3 (sk) |
ES (1) | ES2278018T3 (sk) |
HK (1) | HK1072772A1 (sk) |
HR (1) | HRP20041048B1 (sk) |
HU (1) | HU230032B1 (sk) |
IL (1) | IL164645A (sk) |
MX (1) | MXPA04010313A (sk) |
NO (1) | NO329327B1 (sk) |
NZ (1) | NZ536551A (sk) |
PA (1) | PA8571201A1 (sk) |
PE (1) | PE20040086A1 (sk) |
PT (1) | PT1505066E (sk) |
SI (1) | SI1505066T1 (sk) |
SK (1) | SK288052B6 (sk) |
UA (1) | UA76866C2 (sk) |
UY (1) | UY27762A1 (sk) |
WO (1) | WO2003089425A1 (sk) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010013472A (ja) * | 2009-09-09 | 2010-01-21 | Faes Farma Sa | 4−[2−[1−(2−エトキシエチル)−1H−ベンズイミダゾール−2−イル]−1−ピペリジニル]エチル]−α,α−ジメチルベンゼノ酢酸の多形体 |
WO2013001731A1 (ja) * | 2011-06-30 | 2013-01-03 | パナソニック株式会社 | 通信システム、ユーザ端末並びに通信装置 |
CN102675101B (zh) * | 2012-05-16 | 2014-01-29 | 王蕾 | 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法 |
CZ307500B6 (cs) | 2012-08-15 | 2018-10-24 | Zentiva, K.S. | Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty |
CN103214454A (zh) * | 2013-03-30 | 2013-07-24 | 北京万全德众医药生物技术有限公司 | 一种比拉斯汀晶型及制备方法 |
WO2014188453A2 (en) * | 2013-05-24 | 2014-11-27 | Msn Laboratories Private Limited | Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid |
CN103356616A (zh) * | 2013-06-29 | 2013-10-23 | 北京万全德众医药生物技术有限公司 | 一种含有比拉斯汀的药物组合物及其制备方法 |
CN104447682A (zh) * | 2013-09-12 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 比拉斯汀化合物 |
CN104398481A (zh) * | 2014-10-29 | 2015-03-11 | 万全万特制药江苏有限公司 | 比拉斯汀口崩片及其制备方法 |
CA2993134A1 (en) * | 2015-07-24 | 2017-02-02 | Urquima, S.A. | Crystalline forms of bilastine and preparation methods thereof |
EP3170817A1 (en) | 2015-11-20 | 2017-05-24 | Faes Farma, S.A. | Co-crystals of benzimidazole compounds |
EP3170816A1 (en) * | 2015-11-20 | 2017-05-24 | Faes Farma, S.A. | Supersaturated compositions of benzimidazole compounds |
WO2017167949A1 (en) | 2016-04-01 | 2017-10-05 | Krka, D.D., Novo Mesto | Crystalline forms of bilastine |
WO2017191651A1 (en) * | 2016-05-05 | 2017-11-09 | Msn Laboratories Private Limited, R & D Center | Solid state forms of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl)phenyl]-2-methylpropanoic acid and process for preparation thereof |
EP3453384B1 (en) | 2017-09-07 | 2020-05-27 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical tablet composition comprising bilastine |
EP3641735B1 (en) * | 2017-12-18 | 2021-02-24 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical tablet composition comprising bilastine form 3 and a water-soluble filler |
EP3470062B1 (en) | 2017-12-18 | 2020-10-28 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical tablet composition comprising bilastine polymorphic form 3 and magnesium aluminometasilicate |
WO2019141563A1 (en) | 2018-01-18 | 2019-07-25 | Faes Farma, S.A. | Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent |
CA3200779A1 (en) | 2020-12-23 | 2022-06-30 | Strusi ORAZIO LUCA | A non-micronized bilastine composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4810789A (en) * | 1987-08-28 | 1989-03-07 | Bristol-Myers Company | Process for buspirone hydrochloride polymorphic crystalline form conversion |
ES2124167B1 (es) * | 1996-06-04 | 1999-09-16 | Espanola Prod Quimicos | Nuevos derivados del bencimidazol con actividad antihistaminica. |
BR0010683A (pt) * | 1999-04-16 | 2003-07-01 | Reddy Research Foundation | Formas polimórficas de um agente antidiabético: processo para seu preparo e composições farmacêuticas contendo o mesmo |
CO5170421A1 (es) * | 1999-04-23 | 2002-06-27 | Smithkline Beecham Plc | Nuevo compuesto farmaceutico maleico |
-
2002
- 2002-04-19 KR KR1020047016676A patent/KR100673140B1/ko active IP Right Grant
- 2002-04-19 SK SK5020-2004A patent/SK288052B6/sk not_active IP Right Cessation
- 2002-04-19 SI SI200230485T patent/SI1505066T1/sl unknown
- 2002-04-19 ES ES02724323T patent/ES2278018T3/es not_active Expired - Lifetime
- 2002-04-19 AT AT02724323T patent/ATE347550T1/de active
- 2002-04-19 WO PCT/ES2002/000194 patent/WO2003089425A1/es active IP Right Grant
- 2002-04-19 UA UA20041109444A patent/UA76866C2/uk unknown
- 2002-04-19 MX MXPA04010313A patent/MXPA04010313A/es active IP Right Grant
- 2002-04-19 CN CNB028289870A patent/CN1290843C/zh not_active Ceased
- 2002-04-19 HU HU0500241A patent/HU230032B1/hu unknown
- 2002-04-19 CZ CZ2004-1122A patent/CZ305162B6/cs not_active IP Right Cessation
- 2002-04-19 CA CA002484460A patent/CA2484460C/en not_active Expired - Fee Related
- 2002-04-19 NZ NZ536551A patent/NZ536551A/en not_active IP Right Cessation
- 2002-04-19 EP EP02724323A patent/EP1505066B1/en not_active Expired - Lifetime
- 2002-04-19 JP JP2003586146A patent/JP5142448B2/ja not_active Expired - Lifetime
- 2002-04-19 PT PT02724323T patent/PT1505066E/pt unknown
- 2002-04-19 AU AU2002255017A patent/AU2002255017B2/en not_active Expired
- 2002-04-19 US US10/511,822 patent/US7612095B2/en active Active
- 2002-04-19 DE DE60216641T patent/DE60216641T2/de not_active Expired - Lifetime
- 2002-04-19 DK DK02724323T patent/DK1505066T3/da active
- 2002-04-19 BR BRPI0215703A patent/BRPI0215703B8/pt active IP Right Grant
-
2003
- 2003-04-14 PE PE2003000376A patent/PE20040086A1/es active IP Right Grant
- 2003-04-14 UY UY27762A patent/UY27762A1/es not_active Application Discontinuation
- 2003-04-15 AR ARP030101325A patent/AR039423A1/es not_active Application Discontinuation
- 2003-04-16 PA PA20038571201A patent/PA8571201A1/es unknown
-
2004
- 2004-10-17 IL IL164645A patent/IL164645A/en active IP Right Grant
- 2004-11-09 HR HRP20041048AA patent/HRP20041048B1/hr not_active IP Right Cessation
- 2004-11-17 NO NO20044999A patent/NO329327B1/no not_active IP Right Cessation
- 2004-11-18 BG BG108941A patent/BG66302B1/bg unknown
-
2005
- 2005-07-27 HK HK05106418A patent/HK1072772A1/xx not_active IP Right Cessation
-
2007
- 2007-02-23 CY CY20071100259T patent/CY1107564T1/el unknown
-
2009
- 2009-09-16 US US12/561,148 patent/US20100004285A1/en not_active Abandoned
-
2013
- 2013-04-24 CY CY2013015C patent/CY2013015I1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK288052B6 (sk) | Polymorph 1 of bilastine, process for preparing thereof, its antihistaminic and antiallergic use and pharmaceutical preparation containing it | |
EP1513826B1 (en) | New indolylpiperidine derivatives as potent antihistaminic and antiallergic agents | |
KR100626109B1 (ko) | 항진균성 결정성 다형체 및 이를 포함하는 약제학적 조성물 | |
KR20090048364A (ko) | 아고멜라틴의 결정형 ⅵ, 이의 제조 방법 및 이를 함유하는약제학적 조성물 | |
HUT70637A (en) | Tachykinin receptor antagonist benzimidazole derivatives and pharmaceutical compositions containing them | |
EP0579681B1 (en) | Crystalline tiagabine hydrochloride monohydrate, its preparation and use | |
DE69922594T2 (de) | Indazol-Derivate als 5-HT1F agonists | |
EP0517221B1 (en) | [(Arylalkylpiperidine-4-yl)methyl]-2-alpha,3,4,5-tetrahydro-1(2H)-acenaphthylene-1-ones and related compounds, a process for their preparation and their use as medicaments | |
RU2288917C2 (ru) | Полиморф 4-[2-[4-[1-(2-этоксиэтил)-1h-бензимидазол-2-ил]-1-пиперидинил]этил]-альфа, альфа-диметилбензолуксусной кислоты, способ его получения, фармацевтический препарат на его основе и его применение | |
JP2010013472A (ja) | 4−[2−[1−(2−エトキシエチル)−1H−ベンズイミダゾール−2−イル]−1−ピペリジニル]エチル]−α,α−ジメチルベンゼノ酢酸の多形体 | |
JPH0739415B2 (ja) | ピロリジン誘導体 | |
KR100494448B1 (ko) | 항히스타민활성을가지는신규한벤조이미다졸유도체 | |
PL205568B1 (pl) | Polimorf 1 bilastyny, sposoby jego wytwarzania, preparaty farmaceutyczne go zawierające oraz jego zastosowanie | |
JPH08208640A (ja) | ベンズイミダゾール誘導体およびそれを含有する心不全治療薬 | |
JPH01113383A (ja) | 2,4−ジアミノ−(e)−6−[2−(3−ピリジル)エテニル]−1,3,5−トリアジンおよび該化合物を有効成分とする抗潰瘍剤 | |
CZ12566U1 (cs) | Amlodipinhemimaleát a farmaceutický prostředek |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Filing of an spc |
Free format text: PRODUCT NAME: BILASTIN; NAT. REGISTRATION NO/DATE: 24/0912/10-S 20110125; FIRST REGISTRATION: IS IS/1/10/002/01 20100923 Spc suppl protection certif: 5007-2013 Filing date: 20130410 |
|
SPCG | Grant of an spc |
Free format text: PRODUCT NAME: BILASTIN; NAT. REGISTRATION NO/DATE: 24/0912/10-S 20110125; FIRST REGISTRATION: IS IS/1/10/002/01 20100923 Spc suppl protection certif: 166 5007-2013 Filing date: 20130410 Extension date: 20250923 |
|
MK4A | Patent expired |
Expiry date: 20220419 |